Health
SARS-CoV-2 D614G mutation does affect performance of serological assays – News-Medical.Net
In a new study published in The Journal of Infectious Diseases, US researchers considered the emergence of a new SARS-CoV-2 spike protein variant. They compared…
In a new study published in The Journal of Infectious Diseases, US researchers considered the emergence of a new SARS-CoV-2 spike protein variant. They compared spike G614-based assay to the original D614-based assay – pointing towards the development of recognizable, cross-responsive humoral immunity.
The need to understand the coronavirus disease (COVID-19) pandemic caused by the SARS-CoV-2 has turned our eye towards the acquisition and development of population immunity. We know that the human…
-
Noosa News10 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
Business22 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
Noosa News17 hours agoCibaria Noosa, Noosa Heads Review
-
Business16 hours agoCounter drone company surges past $1 billion valuation with new contract win